Qualitative β-hCG urine assays may be misleading in the presence of molar pregnancy: A case report

Journal of Emergency Medicine

Volumn 27, Issue 1, 2004, Pages 43-47

  Davison, Chris M ^a   Kaplan, Richard M ^b   Wenig, Linda N ^b   Burmeister, David ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

molar pregnancy; serum hCG; urine hCG

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; FENTANYL; MEDROXYPROGESTERONE ACETATE; METHOTREXATE;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EMERGENCY WARD; FEMALE; FOLLOW UP; HUMAN; HYDATIDIFORM MOLE; LABORATORY TEST; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SPONTANEOUS ABORTION; URINALYSIS; VAGINA BLEEDING;

ABDOMINAL PAIN; ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; EMERGENCY MEDICINE; FEMALE; HUMANS; HYDATIDIFORM MOLE; NAUSEA; OBESITY; PREDICTIVE VALUE OF TESTS; PREGNANCY; TREATMENT OUTCOME; UTERINE HEMORRHAGE; VOMITING;

EID: 3042522766     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2004.02.009     Document Type: Article

References (23)

1. th edn. 1994;1039-1053 JB Lippincott Company, Philadelphia
2. nd edn. 1992;Williams and Wilkins, Baltimore, MD. 467-71
3. Berkowitz R.S., Im S.S., Bernstein M.R., et al. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 43:1998;81-85
4. th edn. 2003;Lippincott Williams & Wilkins, New York. 1021-3
5. Copeland L.J., Jarrell J.F. Gestational trophoblastic neoplasia. In: Copeland LJ, ed. Textbook of gynecology. 2000;W.B. Saunders Company, New York. 1409-30
6. Coukos G., Makrigiannakis A., Chung J., et al. Complete hydatidiform mole. A disease with a changing profile. J Reprod Med. 44:1999;698-704
7. Cole L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem. 43:1997;2233-2243
8. Hershman J.M. Human chorionic gonadotropin and the thyroid hyperemesis gravidarum and trophoblastic tumors. Thyroid. 9:1999;653-657
9. Cole L.A., Shahabi S., Butler S.A., et al. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic disease. Clin Chem. 47:2001;308-315
10. Cole L.A., Kohorn E.I., Kim G.S. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med. 39:1994;193-200
11. American College of Emergency Physicians. Clinical policy for the initial approach to patients presenting with a chief complaint of vaginal bleeding. Ann Emerg Med. 29:1997;435-458
12. Wu J., Nakamura R. Human circulating tumor markers. Current concepts and clinical applications. 1997;American Society for Clinical Pathology, Chicago, IL. 127-76
13. Clearview HCG II package insert. Cranbury NJ; Wampole Laboratories; 1997
14. Frieze T.W., Mong D.P., Koops M.K. "Hook effect" in prolactinomas case reports and review of the literature. Endocr Pract. 8:2002;296-303
15. Kikuchi H., Ohta A., Takahashi Y., Shibata A., Ohtake T., Watanabe K. High-dose hook effect in an immunochromatography-optical quantitative reader method for myoglobin. Clin Chem. 49:2003;1709-1710
16. Brensing K.A., Dahlmann N., Entzian W., Bidlingmaier F., Klingmuller D. Underestimation of LH and FSH hormone concentrations in a patient with a gonadotropin secreting tumor the high-dose "hook effect" as a methodological and clinical problem. Horm Metab Res. 21:1989;697-698
17. Comtois R., Robert F., Hardy J. Immunoradiometric assays may miss high prolactin levels. Ann Intern Med. 119:1993;173
18. Haller B.L., Fuller K.A., Brown W.S., Koenig J.W., Eveland B.J., Scott M.G. Two automated prolactin immunoassays evaluated with demonstration of a high-dose "hook effect" in one. Clin Chem. 38:1992;437-438
19. Zweig M.H., Csako G. High-dose hook effect in a two site IRMA for measuring thyrotropin. Ann Clin Biochem. 27:1990;494-495
20. Vaidya H.C., Wolf B.A., Garrett N., Catalona W.J., Clayman R.V., Nahm M.H. Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the "hook effect" Clin Chem. 34:1988;2175-2177
21. Butch A.W. Dilution protocols for detection of hook effects/prozone phenomenon. (letter to the editor) Clin Chem. 46:2000;1719-1720
22. Tang M.E., Standage J.C. Dilution protocols for detection of hook effects/prozone phenomenon. (letter to the editor) Clin Chem. 46:2000;1720-1721
23. Butler S.A., Khanlian S.A., Cole L.A. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin Chem. 47:2001;2131-2136